Tilray Inc Cash Flow Conversion Efficiency

Latest as of February 2026: -0.014x

Tilray Inc cash flow conversion efficiency. Based on the latest financial reports, Tilray Inc (TLRY) has a cash flow conversion efficiency ratio of -0.014x as of February 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-21.94 Million ≈ $-15.87 Million USD) by net assets (CA$1.53 Billion ≈ $1.10 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Tilray Inc (2012–2025)

Cash flow conversion efficiency of Tilray Inc from 2012 to 2025. This chart illustrates how Tilray Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Tilray Inc for real-time trading data and today's change.

Tilray Inc Cash Flow Conversion Ratio Explained

Tilray Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Tilray Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tilray Inc ranked by their cash flow conversion efficiency. Also see Tilray Inc stock valuation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Hainan Huluwa Pharmaceutical Group Co Ltd SHG:605199	0.103x
Panin Financial Tbk JK:PNLF	0.014x
Rotshtein TA:ROTS	-0.082x
Ronshin Group A SHE:301231	N/A
FVCBankcorp Inc NASDAQ:FVCB	0.062x
WCM Global Growth Ltd AU:WQG	0.033x
CNlight Co Ltd SHE:002076	-0.085x
Moury Construct SA BR:MOUR	0.210x

Annual Cash Flow Conversion Efficiency for Tilray Inc (2012–2025)

The table below shows the annual cash flow conversion efficiency of Tilray Inc from 2012 to 2025. Review TLRY cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-05-31	CA$1.49 Billion ≈ $1.08 Billion	CA$-94.60 Million ≈ $-68.43 Million	-0.064x	-607.55%
2024-05-31	CA$3.44 Billion ≈ $2.49 Billion	CA$-30.91 Million ≈ $-22.36 Million	-0.009x	-478.05%
2023-05-31	CA$3.33 Billion ≈ $2.41 Billion	CA$7.91 Million ≈ $5.72 Million	0.002x	+105.95%
2022-05-31	CA$4.44 Billion ≈ $3.21 Billion	CA$-177.26 Million ≈ $-128.23 Million	-0.040x	-298.55%
2021-05-31	CA$4.47 Billion ≈ $3.23 Billion	CA$-44.72 Million ≈ $-32.35 Million	-0.010x	+86.24%
2020-05-31	CA$1.33 Billion ≈ $958.73 Million	CA$-96.43 Million ≈ $-69.76 Million	-0.073x	-126.78%
2019-05-31	CA$1.28 Billion ≈ $926.63 Million	CA$-41.10 Million ≈ $-29.73 Million	-0.032x	-566.53%
2018-05-31	CA$910.14 Million ≈ $658.38 Million	CA$-4.38 Million ≈ $-3.17 Million	-0.005x	-124.75%
2017-05-31	CA$203.29 Million ≈ $147.06 Million	CA$3.95 Million ≈ $2.86 Million	0.019x	+168.90%
2016-05-31	CA$26.85 Million ≈ $19.42 Million	CA$-757.62K ≈ $-548.05K	-0.028x	+93.08%
2015-05-31	CA$10.74 Million ≈ $7.77 Million	CA$-4.38 Million ≈ $-3.17 Million	-0.408x	-169.35%
2014-05-31	CA$271.84K ≈ $196.64K	CA$-41.16K ≈ $-29.78K	-0.151x	0.00%
2013-05-31	CA$271.84K ≈ $196.64K	CA$-41.16K ≈ $-29.78K	-0.151x	-17.18%
2012-05-31	CA$333.15K ≈ $241.00K	CA$-43.05K ≈ $-31.14K	-0.129x	--

About Tilray Inc

TO:TLRY Canada Drug Manufacturers - Specialty & Generic

Market Cap

$303.68 Million

CA$419.81 Million CAD

Market Cap Rank

#14448 Global

#425 in Canada

Share Price

CA$3.51

Change (1 day)

-4.62%

52-Week Range

CA$1.15 - CA$19.12

All Time High

CA$26.00